Search by Drug Name or NDC

    NDC 51862-0558-06 Doryx 200 mg/1 Details

    Doryx 200 mg/1

    Doryx is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma Commercial LLC. The primary component is DOXYCYCLINE HYCLATE.

    Product Information

    NDC 51862-0558
    Product ID 51862-558_fcef6d47-ec45-d10e-e053-6294a90a3416
    Associated GPIs 04000020100650
    GCN Sequence Number 070917
    GCN Sequence Number Description doxycycline hyclate TABLET DR 200 MG ORAL
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 34586
    HICL Sequence Number 004013
    HICL Sequence Number Description DOXYCYCLINE HYCLATE
    Brand/Generic Brand
    Proprietary Name Doryx
    Proprietary Name Suffix n/a
    Non-Proprietary Name doxycycline hyclate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name DOXYCYCLINE HYCLATE
    Labeler Name Mayne Pharma Commercial LLC
    Pharmaceutical Class Tetracycline-class Drug [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050795
    Listing Certified Through n/a

    Package

    NDC 51862-0558-06 (51862055806)

    NDC Package Code 51862-558-06
    Billing NDC 51862055806
    Package 60 TABLET, DELAYED RELEASE in 1 BOTTLE (51862-558-06)
    Marketing Start Date 2015-04-13
    NDC Exclude Flag N
    Pricing Information N/A